No attachments available.
A--Drug Manufacturing and Formulation Program (DMFP)
Contact and place of performance
PLUGGE, RIEKA N
Albany, NY
USA
Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00.
The National Institutes of Health (NIH) NIDA issued an award notice for the Drug Manufacturing and Formulation Program (DMFP) under solicitation number 75N95024R00077. This program involves four Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with a maximum ordering value of $49,999,999.00 and an ordering period spanning from May 4, 2026, through May 3, 2036. The initial task orders were issued concurrently to each awardee on May 4, 2026, totaling $5,000.00 in firm-fixed-price awards for performance through July 3, 2026.
This requirement is classified under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC AN11 for Health R&D Services; Health Care Services; Basic Research. No set-aside was used for this procurement. Performance for these activities will take place in Albany, NY, with Rieka N. Plugge serving as the point of contact. The original notice was published and updated on May 5, 2026, and the record includes no additional attachments.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.